159 related articles for article (PubMed ID: 17948979)
1. Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases.
Graczyk PP
J Med Chem; 2007 Nov; 50(23):5773-9. PubMed ID: 17948979
[TBL] [Abstract][Full Text] [Related]
2. Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.
Sciabola S; Stanton RV; Wittkopp S; Wildman S; Moshinsky D; Potluri S; Xi H
J Chem Inf Model; 2008 Sep; 48(9):1851-67. PubMed ID: 18717582
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of kinase inhibitor fragments.
Bamborough P; Brown MJ; Christopher JA; Chung CW; Mellor GW
J Med Chem; 2011 Jul; 54(14):5131-43. PubMed ID: 21699136
[TBL] [Abstract][Full Text] [Related]
4. Chemical fragments as foundations for understanding target space and activity prediction.
Sutherland JJ; Higgs RE; Watson I; Vieth M
J Med Chem; 2008 May; 51(9):2689-700. PubMed ID: 18386916
[TBL] [Abstract][Full Text] [Related]
5. A quantitative analysis of kinase inhibitor selectivity.
Karaman MW; Herrgard S; Treiber DK; Gallant P; Atteridge CE; Campbell BT; Chan KW; Ciceri P; Davis MI; Edeen PT; Faraoni R; Floyd M; Hunt JP; Lockhart DJ; Milanov ZV; Morrison MJ; Pallares G; Patel HK; Pritchard S; Wodicka LM; Zarrinkar PP
Nat Biotechnol; 2008 Jan; 26(1):127-32. PubMed ID: 18183025
[TBL] [Abstract][Full Text] [Related]
6. Trends in kinase selectivity: insights for target class-focused library screening.
Posy SL; Hermsmeier MA; Vaccaro W; Ott KH; Todderud G; Lippy JS; Trainor GL; Loughney DA; Johnson SR
J Med Chem; 2011 Jan; 54(1):54-66. PubMed ID: 21128601
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a resorcylic acid lactone (RAL) library using fluorous-mixture synthesis and profile of its selectivity against a panel of kinases.
Jogireddy R; Dakas PY; Valot G; Barluenga S; Winssinger N
Chemistry; 2009 Nov; 15(43):11498-506. PubMed ID: 19821461
[TBL] [Abstract][Full Text] [Related]
8. Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.
Gozalbes R; Simon L; Froloff N; Sartori E; Monteils C; Baudelle R
J Med Chem; 2008 Jun; 51(11):3124-32. PubMed ID: 18479119
[TBL] [Abstract][Full Text] [Related]
9. Kinase selectivity profiling by inhibitor affinity chromatography.
Valsasina B; Kalisz HM; Isacchi A
Expert Rev Proteomics; 2004 Oct; 1(3):303-15. PubMed ID: 15966827
[TBL] [Abstract][Full Text] [Related]
10. Affinity purification of proteins binding to kinase inhibitors immobilized on self-assembling monolayers.
Bantscheff M; Hobson S; Kuster B
Methods Mol Biol; 2012; 795():149-60. PubMed ID: 21960221
[TBL] [Abstract][Full Text] [Related]
11. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C
Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005
[TBL] [Abstract][Full Text] [Related]
12. Proteochemometric recognition of stable kinase inhibition complexes using topological autocorrelation and support vector machines.
Fernandez M; Ahmad S; Sarai A
J Chem Inf Model; 2010 Jun; 50(6):1179-88. PubMed ID: 20524632
[TBL] [Abstract][Full Text] [Related]
13. Diversity-oriented synthesis of pochonins and biological evaluation against a panel of kinases.
Moulin E; Barluenga S; Totzke F; Winssinger N
Chemistry; 2006 Nov; 12(34):8819-34. PubMed ID: 16953513
[TBL] [Abstract][Full Text] [Related]
14. Redesigning kinase inhibitors to enhance specificity.
Crespo A; Zhang X; Fernández A
J Med Chem; 2008 Aug; 51(16):4890-8. PubMed ID: 18680272
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and target identification of hymenialdisine analogs.
Wan Y; Hur W; Cho CY; Liu Y; Adrian FJ; Lozach O; Bach S; Mayer T; Fabbro D; Meijer L; Gray NS
Chem Biol; 2004 Feb; 11(2):247-59. PubMed ID: 15123286
[TBL] [Abstract][Full Text] [Related]
16. Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.
Vieth M; Higgs RE; Robertson DH; Shapiro M; Gragg EA; Hemmerle H
Biochim Biophys Acta; 2004 Mar; 1697(1-2):243-57. PubMed ID: 15023365
[TBL] [Abstract][Full Text] [Related]
17. Turning promiscuous kinase inhibitors into safer drugs.
Zhang X; Crespo A; Fernández A
Trends Biotechnol; 2008 Jun; 26(6):295-301. PubMed ID: 18403035
[TBL] [Abstract][Full Text] [Related]
18. Classification of kinase inhibitors using a Bayesian model.
Xia X; Maliski EG; Gallant P; Rogers D
J Med Chem; 2004 Aug; 47(18):4463-70. PubMed ID: 15317458
[TBL] [Abstract][Full Text] [Related]
19. [Progress in the design of selective ATP-competitive kinase inhibitors].
Deng XQ; Xiang ML; Jia R; Yang SY
Yao Xue Xue Bao; 2007 Dec; 42(12):1232-6. PubMed ID: 18338633
[TBL] [Abstract][Full Text] [Related]
20. Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.
Vieth M; Erickson J; Wang J; Webster Y; Mader M; Higgs R; Watson I
J Med Chem; 2009 Oct; 52(20):6456-66. PubMed ID: 19791746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
